Haemodialysis-associated amyloidosis: Difference between revisions
Content deleted Content added
No edit summary |
Simple Bob (talk | contribs) Reverted 1 edit by The.aviation.expert (talk): Nonsense - it is a well-sourced article and this is not a criteria for deletion. (TW) |
||
| Line 1: | Line 1: | ||
{{db-short}} |
|||
{{Infobox disease |
{{Infobox disease |
||
| Name = {{PAGENAME}} |
| Name = {{PAGENAME}} |
||
Revision as of 08:25, 6 August 2011
| Haemodialysis-associated amyloidosis | |
|---|---|
| Specialty | Immunology  |
Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.[1]
Presentation
Long-term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood.[2] It accumulates because it is unable to cross the dialysis filter.
Prevention
Low copper dialysis is theorized to prevent or delay onset.[3]
See also
References
- ^ Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.
{{cite book}}: CS1 maint: multiple names: authors list (link) - ^ "BU Amyloid Treatment & Research Program".
 | This dermatology article is a stub. You can help Wikipedia by expanding it. |